Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency
- 21 August 2013
- journal article
- case report
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 173 (12) , 1591-1594
Abstract
Bordetella pertussis or whooping cough is a vaccine-preventable disease that still remains a serious infection in neonates and young infants. We describe two young infants, monozygotic twins, with a severe B. pertussis pneumonia of whom one needed extracorporeal membrane oxygenation. Diagnostic work-up of unexplained hematuria and proteinuria during the illness revealed low serum complement component 3 (C3) levels. During follow-up, C3 levels remained low (400–600 mg/L). Extensive analysis of the persistent low C3 levels revealed an unknown heterozygous mutation in the C3 gene in both siblings and their mother. This C3 mutation in combination with the specific virulence mechanisms of B. pertussis probably contributed to the severe disease course in these cases. Conclusion: We propose that genetically caused complement disorders should be considered when confronted with severe cases of B. pertussis infection.Keywords
This publication has 10 references indexed in Scilit:
- Interactions between Bordetella pertussis and the complement inhibitor factor HMolecular Immunology, 2011
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase FormationScience, 2010
- Infections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyClinical Microbiology Reviews, 2010
- Evidence for an intact polysaccharide capsule in Bordetella pertussisMicrobes and Infection, 2010
- MATERNALLY DERIVED ANTIBODIES AGAINST BORDETELLA PERTUSSIS ANTIGENS PERTUSSIS TOXIN AND FILAMENTOUS HEMAGGLUTININ IN PRETERM AND FULL TERM NEWBORNSThe Pediatric Infectious Disease Journal, 2009
- The case for maternal vaccination against pertussisThe Lancet Infectious Diseases, 2007
- Bordetella pertussisBinds Human C1 Esterase Inhibitor during the Virulent Phase, to Evade Complement‐Mediated KillingThe Journal of Infectious Diseases, 2007
- Recent developments in pertussisThe Lancet, 2006
- Activation of the complement cascade by Bordetella pertussisFEMS Microbiology Letters, 2003
- Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutininInfection and Immunity, 1997